December 28, 2017 / 12:25 AM / in 6 months

Aveo settles investor lawsuit over cancer drug for $15 mln, warrants

Aveo Pharmaceuticals Inc will settle claims it misled shareholders about the Food and Drug Administration’s concerns regarding a kidney cancer drug it was developing by paying $15 million out of insurance and issuing warrants for affected investors to buy 2 million shares.

The biotech company filed papers in federal court in Boston on Wednesday saying it had reached a settlement, the terms of which it disclosed in a filing with the U.S. Securities and Exchange Commission a day earlier.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2pItOYf

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below